05.09.2019 • News

Arcinova Appoints Roger Kilburn as CEO

Arcinova has appointed Roger Kilburn as its new CEO. Source: Arcinova
Arcinova has appointed Roger Kilburn as its new CEO. Source: Arcinova

UK-based contract development and manufacturing organization (CDMO) Arcinova has appointed Roger Kilburn as its new CEO, effective immediately. The previous CEO, Ian Shott, has assumed the position of executive chairman.

Kilburn has more than 25 years of international experience in the pharmaceutical and chemical industries. He has worked in a variety of roles within general management, marketing, sales, manufacturing, projects and engineering. Prior to his most recent position as CEO of IBioIC, Kilburn worked for Johnson Matthey and ICI in business leader positions. He holds a 1st class honors degree in chemical engineering from the University of Glamorgan.

Ian Shott commented, “I am delighted that Roger is taking over this crucial role and certain that his experience leading both Macfarlan Smith in Edinburgh and JM Pharma Services in Boston, Massachusetts gives him an excellent foundation to steer Arcinova through its critical scale up phase, creating a strong and sustainable medium sized enterprise.”

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read